Manufacturing BMS banks on Texas for $2.3bn multi-modal manufacturing facility Pharmaceutical TechnologyThis will establish BMS' in-house manufacturing presence in Texas, adding to its ongoing outlicensing and research partnerships in the state.Read full story pharminent August 11, 2026 (Last updated: August 11, 2026) Pharmaceutical Technology This will establish BMS’ in-house manufacturing presence in Texas, adding to its ongoing outlicensing and research partnerships in the state. Read full story Post navigation Previous: Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfrontNext: UK regulators greenlight Lilly’s Foundayo, intensifying Novo competition Related Stories Manufacturing AsymBio to secure $184m to support growth in biologics manufacturing pharminent August 5, 2026 Manufacturing Lilly and Resilience invest $750M in diabetes and obesity drug device supply pharminent July 31, 2026 Manufacturing GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy pharminent July 29, 2026
